Agilon Other Non Cash Items from 2010 to 2024

AGL Stock  USD 1.78  0.11  6.59%   
Agilon Health Other Non Cash Items yearly trend continues to be quite stable with very little volatility. The value of Other Non Cash Items is projected to decrease to about 20.4 M. From the period between 2010 and 2024, Agilon Health, Other Non Cash Items regression line of its data series had standard deviation of  53,998,578 and standard deviation of  53,998,578. View All Fundamentals
 
Other Non Cash Items  
First Reported
2018-12-31
Previous Quarter
21.8 M
Current Value
32.8 M
Quarterly Volatility
18.7 M
 
Covid
Check Agilon Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agilon Health's main balance sheet or income statement drivers, such as Tax Provision of 936.1 K, Interest Income of 5.6 M or Discontinued Operations of 561.5 K, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0 or PTB Ratio of 8.14. Agilon financial statements analysis is a perfect complement when working with Agilon Health Valuation or Volatility modules.
  
Check out the analysis of Agilon Health Correlation against competitors.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.

Latest Agilon Health's Other Non Cash Items Growth Pattern

Below is the plot of the Other Non Cash Items of agilon health over the last few years. It is Agilon Health's Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agilon Health's overall financial position and show how it may be relating to other accounts over time.
Other Non Cash Items10 Years Trend
Slightly volatile
   Other Non Cash Items   
       Timeline  

Agilon Other Non Cash Items Regression Statistics

Arithmetic Mean78,987,587
Geometric Mean57,998,035
Coefficient Of Variation68.36
Mean Deviation48,337,884
Median115,241,000
Standard Deviation53,998,578
Sample Variance2915.8T
Range132.8M
R-Value(0.78)
Mean Square Error1245.8T
R-Squared0.60
Significance0.0007
Slope(9,378,134)
Total Sum of Squares40821.8T

Agilon Other Non Cash Items History

202420.4 M
202327 M
2022-7.2 M
20219.8 M
2020-17.6 M

About Agilon Health Financial Statements

Agilon Health investors utilize fundamental indicators, such as Other Non Cash Items, to predict how Agilon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Other Non Cash Items27 M20.4 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports:
Check out the analysis of Agilon Health Correlation against competitors.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
11.951
Earnings Share
(0.76)
Revenue Per Share
13.717
Quarterly Revenue Growth
0.276
Return On Assets
(0.1)
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.